Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Open-market sale CEO sold 6,261 shares at $59.11 ($370,088)
  2. 4 Open-market sale CFO sold 1,787 shares at $59.11 ($105,630)
  3. 4 Derivatives Options or other derivatives
  4. 4/A Open-market sale CEO sold 50,000 shares at an average $66.84 ($3,341,903)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Option exercise President & CSO acquired 39,700 shares (option exercise)
  8. 4 Open-market sale President & CSO sold 2,607 shares at an average $86.13 ($224,531)
  9. 4 Open-market sale President & CSO sold 29,393 shares at an average $85.62 ($2,516,672)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale CEO sold 47,700 shares at an average $83.80 ($3,997,268)
  13. 4 Option exercise President & CSO acquired 18,012 shares (option exercise)
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. 4 Other disposition See Remark 1 disposed of 2,600,505 shares (other)
  17. 4 Open-market sale CEO sold 20,000 shares at an average $99.49 ($1,989,744)
  18. 4/A Other disposition 10% owner disposed of 1,913,277 shares (other)
  19. 4 Other disposition See Remark 1 disposed of 1,913,277 shares (other)
  20. 4 Open-market sale Director sold 2,614 shares at an average $120.61 ($315,263)

Page 9 of 12 · 238 filings